Diagnostic & Research Center for Molecular Biomedicine, Diagnostic & Research Institute of Pathology, Medical University of Graz, A-8010 Graz, Austria.
Int J Mol Sci. 2021 Nov 21;22(22):12545. doi: 10.3390/ijms222212545.
Understanding the pathomechanism of steatohepatitis (SH) is hampered by the difficulty of distinguishing between causes and consequences, by the broad spectrum of aetiologies that can produce the phenotype, and by the long time-span during which SH develops, often without clinical symptoms. We propose that SH develops in four phases with transitions: (i) priming lowers stress defence; (ii) triggering leads to acute damage; (iii) adaptation, possibly associated with cellular senescence, mitigates tissue damage, leads to the phenotype, and preserves liver function at a lower level; (iv) finally, senescence prevents neoplastic transformation but favours fibrosis (cirrhosis) and inflammation and further reduction in liver function. Escape from senescence eventually leads to hepatocellular carcinoma. This hypothesis for a pathomechanism of SH is supported by clinical and experimental observations. It allows organizing the various findings to uncover remaining gaps in our knowledge and, finally, to provide possible diagnostic and intervention strategies for each stage of SH development.
我们提出,脂肪性肝炎(SH)的发生可分为四个阶段,并存在转变:(i)启动会降低应激防御;(ii)触发会导致急性损伤;(iii)适应,可能与细胞衰老有关,可减轻组织损伤,导致表型,并在较低水平上维持肝功能;(iv)最后,衰老会阻止肿瘤转化,但有利于纤维化(肝硬化)和炎症,并进一步降低肝功能。逃避衰老最终会导致肝细胞癌。这一 SH 发病机制的假说得到了临床和实验观察的支持。它可以将各种发现组织起来,揭示我们知识中的空白,并最终为 SH 发展的每个阶段提供可能的诊断和干预策略。